Zobrazeno 1 - 10
of 846
pro vyhledávání: '"CMTNS"'
Autor:
Wang, Wenjia1,2 wenjia.wang@pharnext.com, Guedj, Mickaël2, Bertrand, Viviane2, Foucquier, Julie2, Jouve, Elisabeth3, Commenges, Daniel1, Proust-Lima, Cécile1, Murphy, Niall P.2, Blin, Olivier3, Magy, Laurent4, Cohen, Daniel2, Attarian, Shahram5
Publikováno v:
PLoS ONE. 1/17/2017, Vol. 12 Issue 1, p1-14. 14p.
Autor:
Mandel, Jonas1 jmandel@pharnext.com, Bertrand, Viviane1, Lehert, Philippe2,3, Attarian, Shahram4, Magy, Laurent5, Micallef, Joëlle6, Chumakov, Ilya1, Scart-Grès, Catherine1, Guedj, Mickael1, Cohen, Daniel1
Publikováno v:
Orphanet Journal of Rare Diseases. Jun2015, Vol. 10 Issue 1, p1-4. 4p.
Publikováno v:
Frontiers in Microbiology, Vol 10 (2019)
Cordyceps militaris, a valuable edible and medicinal fungus, has attracted increasing attention because of its various bioactive ingredients. However, the biosynthetic pathway of C. militaris carotenoids is still unknown due to lack of transcriptome
Externí odkaz:
https://doaj.org/article/ab4f4a84cfc945e5a3b9ef55fa36500c
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Wenjia Wang, Mickaël Guedj, Viviane Bertrand, Julie Foucquier, Elisabeth Jouve, Daniel Commenges, Cécile Proust-Lima, Niall P Murphy, Olivier Blin, Laurent Magy, Daniel Cohen, Shahram Attarian
Publikováno v:
PLoS ONE, Vol 12, Iss 1, p e0169878 (2017)
The Charcot-Marie-Tooth Neuropathy Score (CMTNS) was developed as a main efficacy endpoint for application in clinical trials of Charcot-Marie-Tooth disease type 1A (CMT1A). However, the sensitivity of the CMTNS for measuring disease severity and pro
Externí odkaz:
https://doaj.org/article/1ed5e395f7894e9c845085b6ded2e1f7
Autor:
Chen, Tao1 (AUTHOR), Hou, Peidong1 (AUTHOR), Zhang, Yafei1 (AUTHOR), Ao, Rujiang1 (AUTHOR), Su, Lichao1 (AUTHOR), Jiang, Yifan1 (AUTHOR), Zhang, Yuanli1 (AUTHOR), Cai, Huilan1 (AUTHOR), Wang, Jun1 (AUTHOR), Chen, Qiushui1 (AUTHOR), Song, Jibin1 (AUTHOR), Lin, Lisen1 (AUTHOR) lisen.lin@fzu.edu.cn, Yang, Huanghao1 (AUTHOR) hhyang@fzu.edu.cn, Chen, Xiaoyuan2,3,4 (AUTHOR) chen.shawn@nus.edu.sg
Publikováno v:
Angewandte Chemie. 6/25/2021, Vol. 133 Issue 27, p15133-15139. 7p.
Autor:
Philippe Lehert, Catherine Scart-Grès, Viviane Bertrand, Mickaël Guedj, Laurent Magy, Daniel Cohen, Jonas Mandel, Shahram Attarian, Joëlle Micallef, Ilya Chumakov
Publikováno v:
Orphanet Journal of Rare Diseases
Orphanet Journal of Rare Diseases, 2015
Orphanet Journal of Rare Diseases, BioMed Central, 2015
Orphanet Journal of Rare Diseases, 2015
Orphanet Journal of Rare Diseases, BioMed Central, 2015
International audience; CMT1A is the most common inherited peripheral neuropathy. There is currently no approved treatment. We performed a meta-analysis including four randomized, double-blind, Placebo-controlled clinical trials to assess the disease
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::817d23ba5e029e914eedc9a3779556e0
https://hal-amu.archives-ouvertes.fr/hal-01203428/file/s13023-015-0293-y.pdf
https://hal-amu.archives-ouvertes.fr/hal-01203428/file/s13023-015-0293-y.pdf
Autor:
Prada, Valeria1,2 (AUTHOR) Valeria-prada@uiowa.edu, Zuccarino, Riccardo3 (AUTHOR), Schenone, Cristina1 (AUTHOR), Mennella, Giulia1 (AUTHOR), Grandis, Marina1,4 (AUTHOR), Shy, Michael E.2 (AUTHOR), Schenone, Angelo1,4 (AUTHOR)
Publikováno v:
Neurological Sciences. Apr2022, Vol. 43 Issue 4, p2759-2764. 6p. 2 Charts, 3 Graphs.
Autor:
Mickaël Guedj, Wenjia Wang, Laurent Magy, Daniel Commenges, Julie Foucquier, Niall P. Murphy, Cécile Proust-Lima, Olivier Blin, Elisabeth Jouve, Shahram Attarian, Viviane Bertrand, Daniel Cohen
Publikováno v:
PLoS ONE
PLoS ONE, 2017, 12 (1), pp.e0169878. ⟨10.1371/journal.pone.0169878⟩
PLoS ONE, Vol 12, Iss 1, p e0169878 (2017)
PLoS ONE, 2017, 12 (1), pp.e0169878. ⟨10.1371/journal.pone.0169878⟩
PLoS ONE, Vol 12, Iss 1, p e0169878 (2017)
International audience; The Charcot-Marie-Tooth Neuropathy Score (CMTNS) was developed as a main efficacy endpoint for application in clinical trials of Charcot-Marie-Tooth disease type 1A (CMT1A). However, the sensitivity of the CMTNS for measuring
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33e7171c920b24877a29e11bad4c47d5
https://hal.science/hal-03598218
https://hal.science/hal-03598218
Autor:
Tozza, Stefano1 (AUTHOR) ste.tozza@gmail.com, Bruzzese, Dario2 (AUTHOR), Severi, Daniele1 (AUTHOR), Spina, Emanuele1 (AUTHOR), Iodice, Rosa1 (AUTHOR), Ruggiero, Lucia1 (AUTHOR), Dubbioso, Raffaele1 (AUTHOR), Iovino, Aniello1 (AUTHOR), Aruta, Francesco1 (AUTHOR), Nolano, Maria1 (AUTHOR), Santoro, Lucio1 (AUTHOR), Manganelli, Fiore1 (AUTHOR)
Publikováno v:
Neurological Sciences. Jan2022, Vol. 43 Issue 1, p559-563. 5p. 3 Charts, 1 Graph.